Remove EHR Remove Interoperability Remove Meaningful Use Remove mHealth
article thumbnail

Who will regulate mHealth? Patient Engagement at Crossroads; New Alliance Takes On Interoperability

Chilmark Research

mHealth, known for rapid innovation and iteration, has a tendency to buck at the snail’s pace of FDA regulation. This could herald a new age of credibility for mHealth. They will need to tread carefully to maintain their objectivity in both certifying apps while at the same time providing a marketplace for mHealth apps.

mHealth 60
article thumbnail

The The Five Biggest Areas of Opportunity for Digital Health

The Digital Health Corner

Electronic health records (EHRs) and personal fitness trackers have helped create awareness through use. According to most recent statistics from the Office of the National Coordinator, use of EHRs has increased from 20% in 2004 to 87% in 2015. We need EHRs which are clinically oriented with good user interfaces.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Three Big Questions for Stage 3 & Patient Engagement

Chilmark Research

For many, the delay of Stage 3 of the Meaningful Use program evoked a collective sigh of relief, providing a much-needed extra year to focus on the challenging requirements for patient engagement and interoperability. Each of these use cases brings with it a unique set of programmatic and technical components.

article thumbnail

Review of Mobile Devices and Health by Ida Sim in the NEJM

mHealth Insight

who is a Primary Care Physician, Professor at UCSF & coFounder at Open mHealth (follow her on Twitter @IdaSim ). mHealth Insights. Widely used in the social and behavioral sciences, EMA is an emerging method for outcomes assessment in both clinical care and clinical research. Authored by Ida Sim, M.D.,